Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

AGM Statement

15 Dec 2016 07:00

RNS Number : 9005R
Falanx Group Limited
15 December 2016
 

Falanx Group Limited

("Falanx" or "the Company")

 

ANNUAL GENERAL MEETING STATEMENT AND TRADING UPDATE

 

Falanx Group (AIM:FLX), the global intelligence, security and cyber defence provider, is pleased to provide an update on its current trading, ahead of the Company's Annual General Meeting, which will be held today at 10:00am at the offices of DWF LLP at 31st Floor, 20 Fenchurch Street, London EC3M 3AGr.

 

Trading Update

 

The Company is pleased to announce further progress in its third quarter, in line with the guidance given in its interim results released on 1 November 2016, with highlights as follows:

 

· Falanx Cyber Defence has secured its first FTSE100 Banking and Retail Financial Services client. Initial revenue of £0.4m is expected to be generated in the current financial year.

· Falanx Intelligence has additional contracts to provide embedded expertise and increased services to a FTSE100 Telecoms Major and a FTSE100 Audit and Consultancy organisation, generating £0.24m and £0.23m respectively in this financial year.

· Focus on the Financial Services sector is proving successful, with a total of £1.25m of revenue being generated in this financial year by the provision of Intelligence and Cyber Defence services to a wide range of Banking, Fund Management, Trading and Financial Support services.

· On track for planned organic growth in H2, with significant staff hiring programme.

· Sufficient cash to fund H2 organic needs on a debt free basis.

 

The above described contracts, together with an ongoing focus on the Financial Services sector, have contributed to a good financial performance by the Company in the third quarter. It is clear that cyber-security and hacking is only increasing as an issue, not just for larger firms, but also for mid-sized firms who are handling sensitive transactions and significant sums of capital, but often unable to fund enlarged security teams within their smaller operational budgets. These firms are now looking to buy in their cyber defense and intelligence as a managed service and this mid-market is maturing quickly as a result.

 

Outlook

Falanx continues to make considerable progress in 2016, both in terms of its financial performance, contract wins and the strengthening of our senior executive team. We are engaged in a significant recruitment push across the business, which will, in turn, underpin our continued drive to positive cash flow from operations next year. As a consequence of the quality of our people and our offering, and the continued growth of the markets in which Falanx operates, we look forward to reporting full-year revenue in line with our expectations and, with considerable confidence, to 2017.

 

A downloadable copy of the CEO's presentation for the 2016 AGM can be found at;

 

http://www.falanxgroup.com/aim-rule-26/announcements/

Enquiries:

 

Falanx Group Limited

Stuart Bladen, Chief Executive

 

 

 

via Walbrook PR

www.falanxgroup.com

www.falanxassuria.com

www.falanxcyberdefence.com

Panmure Gordon (UK) Limited

Nominated Adviser & Joint Broker

Andrew Godber / Peter Steel

 

+44 (0) 20 7886 2500

Whitman Howard Limited

Joint Broker

Nick Lovering / Francis North

 

+44 (0) 207 659 1234

Walbrook PR (Media and Investor Relations) Paul Cornelius / Nick Rome

+44 (0) 207 933 8780

falanx@walbrookpr.com

 

About Falanx

Falanx Group Limited, is a global intelligence and cyber defence provider working with blue chip and government clients. The Group listed on AIM in June 2013 under ticker FLX For more information: http://www.falanxgroup.com/

 

MAR

This announcement contains inside information for purposes of Article 7 of Regulation (EU) No 596/2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMFFESFIFMSEEE
Date   Source Headline
18th Jan 20212:00 pmRNSPrice Monitoring Extension
13th Jan 20214:41 pmRNSSecond Price Monitoring Extn
13th Jan 20214:35 pmRNSPrice Monitoring Extension
13th Jan 20212:05 pmRNSSecond Price Monitoring Extn
13th Jan 20212:00 pmRNSPrice Monitoring Extension
13th Jan 202111:06 amRNSSecond Price Monitoring Extn
13th Jan 202111:00 amRNSPrice Monitoring Extension
13th Jan 20217:00 amRNSTriarii to include Microsoft Azure Sentinel
18th Dec 20207:00 amRNSUpdate on SolarWinds® Orion® Platform Cyberattack
17th Dec 20202:28 pmRNSResult of AGM
17th Dec 20207:00 amRNSInterim results
1st Dec 20207:00 amRNSTotal Voting Rights
23rd Nov 202010:12 amRNSNotice of AGM
4th Nov 20204:42 pmRNSDirector subscriptions/PDMR dealing and TVR
30th Oct 20204:17 pmRNSPublication of final results & total voting rights
30th Oct 20207:00 amRNSPreliminary results for year ended 31 March 2020
28th Oct 20207:00 amRNSFalanx joins SolarWinds TAP
2nd Oct 20201:53 pmRNSHolding(s) in Company
1st Oct 20202:28 pmRNSHolding(s) in Company
1st Oct 20202:21 pmRNSHolding(s) in Company
29th Sep 20207:00 amRNSConfirmation of successful fundraising
28th Sep 20204:55 pmRNSProposed Equity Fundraise
18th Sep 20207:00 amRNSStrategic Contract Win
21st Aug 202012:16 pmRNSDirector/PDMR Shareholding
17th Aug 20207:00 amRNSStrategic Contract Win
5th Aug 20207:00 amRNSTrading Statement
24th Jul 20207:00 amRNSHolding(s) in Company
24th Jul 20207:00 amRNSHolding(s) in Company
9th Jul 20202:19 pmRNSHolding(s) in Company
21st Apr 20207:00 amRNSSalary sacrifice, grant of options & PDMR dealing
27th Feb 202011:56 amRNSHolding(s) in Company
2nd Jan 20203:21 pmRNSDirector/PDMR Shareholding
20th Dec 20197:00 amRNSSale of Furnace and Directorate Change
3rd Dec 20194:40 pmRNSResult of AGM
3rd Dec 20197:00 amRNSInterim Results
22nd Nov 201910:18 amRNSHolding(s) in Company
11th Nov 20197:00 amRNSTrading update, notice of results & notice of AGM
25th Sep 20197:30 amRNSGrant of Share Options
25th Sep 20197:00 amRNSDirector/PDMR Shareholding
24th Sep 201911:37 amRNSDirector/PDMR Shareholding
23rd Sep 20193:13 pmRNSAvailability of report and accounts
19th Sep 20197:00 amRNSAnnual results for the year ended 31 March 2019
31st May 201911:39 amRNSDirector/PDMR Shareholding
29th May 20197:00 amRNSChange of Adviser
28th Mar 20197:00 amRNSDirectorate Change
22nd Mar 20197:00 amRNSChange of Adviser
18th Feb 201910:32 amRNSDirector / PDMR Shareholding
18th Feb 201910:18 amRNSDirector / PDMR Shareholding
21st Dec 20181:01 pmRNSGrant of Share Options
21st Dec 201812:47 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.